Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-014499
Filing Date
2025-02-05
Accepted
2025-02-05 16:17:40
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3973
  Complete submission text file 0000950170-25-014499.txt   5393
Mailing Address 12406 HORESHAM STREET CARMEL IN 46032
Business Address 12406 HORESHAM STREET CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Issuer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MBX BIOSCIENCES, INC. 11711 N. MERIDIAN STREET, SUITE 300 CARMEL IN 46032
Business Address
Azoulay Salomon (Reporting) CIK: 0002030246 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42272 | Film No.: 25593541